Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Liver Cancer
 More »

  • MultiCell, Genisphere to Target Liver Cancer with Nanoparticles
    MultiCell Technologies and Genisphere are working together to develop a targeted MCT-485 nanoparticle therapeutic for the treatment of liver cancer. MCT-485 is a noncoding, ...
    8-6-2013
  • Onyx Spurns Amgen Offer, Pursues Its Own Deal
    (HCC), which is the most common form of liver cancer, advanced renal cell carcinoma (RCC) or kidney cancer; and the blood cancer treatment Stivarga (regorafenib) for injection. ...
    7-1-2013
  • Unraveling the Transcriptome
    ... personal transcriptome profiling in cancer and other diseases," Dr. Gerstein says. ... Liver RNA from rats exposed to Aflatoxin B1 was analyzed by RNA-Seq or microarray: Reads ...
    7-1-2013
  • Exploring Exosomal RNA
    Novartis' Maja M. Janas, Ph.D., is working to identify miRNAs commonly enriched or reduced in exosomes across eight different liver cancer cell lines as part of a larger effort to ...
    6-15-2013
  • Deciphering the Mysteries in Lipid Biology
    ... Comparison of the expression profiles of normal and cancer cells directs researchers' ... in genes encoding sterol metabolic enzymes lead to serious liver and endocrine problems. ...
    6-1-2013
  • Roswell Park Joins Jasco to Develop Lead Agent for Cancer
    cancer cell survival. In preclinical studies, Jasco's lead agent has shown promising activity against multiple myeloma as well as solid tumors that include breast, colon, liver, ...
    5-31-2013
  • Nordion Sells TheraSphere to BTG for $200M
    Nordion said today it will sell its liver cancer drug to U.K.-based BTG for $200 million cash, leaving the Canadian company with its specialty medical isotope business four months ...
    5-23-2013
  • Top 20 Grant-Giving Disease Foundations
    ... American Liver Foundation % of Revenue Awarded as Grants: 11.1% 2011 Total Revenues, ... Headquarters: New York, NY #16. American Cancer Society 3 % of Revenue Awarded: 11.5% ...
    5-21-2013
  • Softening the Blow from FOLFOX Treatment
    ... for magnetic resonance imaging in the liver: When injected too rapidly, patients' ... many types of cancer, but which damaged the DNA in cancer cells, causing them to die. ...
    5-15-2013
  • Mirna Initiates PI Trial for miRNA Candidate Cancer Drug
    The trial, which is expected to enroll up to 48 patients with unresectable primary liver cancer or metastatic cancer with liver involvement, will follow a standard oncology study ...
    5-13-2013
  • Metabolomics Advances Reshape Dx Arena
    ... But we also maintain an extensive R&D program identifying disease drivers in cancer." The ... lipid species in plasma and liver samples from wild type and fat-1 mice," said Dr. ...
    5-1-2013
  • Human iPSC-Derived Hepatocytes
    ... the potential to exhibit drug-induced liver injury (DILI) or even idiosyncratic toxicity. ... However, the cancer cell-derived HepG2 line does not exhibit sensitivity to aflatoxin at ...
    5-1-2013
  • Ascletis Obtains Chinese Rights to Janssen HIV Treatment
    RNAi therapeutic for the treatment of liver cancers that is being developed with ... On its own, Ascletis is developing the cancer drug ASC-06 (ALN-VSP), which consists of two ...
    4-30-2013
  • Merck Joins Pfizer to Develop Type 2 Diabetes Drug
    for Forxiga, but FDA rejected the drug in January of last year based on concerns about the risk of cancer and liver injury from the drug and asked for more clinical data. ...
    4-29-2013
  • NanoString Nabs License to Liver Cancer Gene Signature
    used to determine the prognosis of patients diagnosed with the most common type of liver cancer, hepatocellular carcinoma (HCC), or with hepatitis C-related early-stage cirrhosis. ...
    4-17-2013
  • More »

    Journal Articles

  • Information Extraction for Tracking Liver Cancer Patients' Statuses...
    Xiao-Ou Ping, Yi-Ju Tseng, Yufang Chung, Ya-Lin Wu, Ching-Wei Hsu, Pei-Ming Yang, Guan-Tarn Huang, Feipei Lai, Ja-Der Liang
    Telemedicine and e-Health
    Information Extraction for Tracking Liver Cancer Patients' Statuses: From Mixture of Clinical Narrative Report Types Telemedicine and e-Health Introduction: To provide the ...
  • Estrogen Regulation of MicroRNAs, Target Genes, and MicroRNA...
    Amit Cohen, Yoav Smith
    Zebrafish
    of diseases such as cancer. Here we show a remarkable widespread microRNA (miRNA) down-regulation in the zebrafish (Danio rerio) liver following 17ß-estradiol (E2) treatment. ...
  • Functional Identification of a Non-Fusion TRAIL Extracellular...
    Kunpeng Zhao, Xueyin Wang, Yugang Wang, Yuanfang Ma
    Hybridoma
    of transformed cells and is currently being developed as a cancer therapeutic drug. ... apoptosis of Jurkat cells but no cytotoxicity to human liver cells and PBMC was observed. ...
  • CD146 Protein as a Marker to Predict Postoperative Liver Metastasis...
    Buxian Tian, Yuhong Zhang, Nan Li
    Cancer Biotherapy and Radiopharmaceuticals
    CD146 Protein as a Marker to Predict Postoperative Liver Metastasis in Colorectal Cancer Cancer Biotherapy and Radiopharmaceuticals Objective: To study the expression and ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll